ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Menlo Therapeutics Inc

Menlo Therapeutics Inc (MNLO)

1.35
0.00
(0.00%)
Closed 24 November 8:00AM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.35
Bid
1.36
Offer
1.37
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.35
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
13,957,000
Dividend Yield
-
PE Ratio
-1.49
Earnings Per Share (EPS)
-2.04
Revenue
424k
Net Profit
-28.45M

About Menlo Therapeutics Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-

MNLO Latest News

Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Menlo Therapeutics Inc. Securities Settlement: SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF...

Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the...

Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin

REDWOOD CITY, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced results from its Phase 2 clinical trial...

Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chr...

REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced it will host a conference call and webcast...

Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Pso...

REDWOOD CITY, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd. PR Newswire NEW YORK, Nov. 12, 2019 NEW YORK, Nov. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

Menlo Therapeutics Reports Third Quarter 2019 Financial Results and Provides Program Updates

REDWOOD CITY, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics Announces Completion of Enrollment in Two Phase 3 Trials of Serlopitant in Prurigo Nodularis

- Pivotal results expected in March/April 2020 - - Details of the program to be reviewed at company’s Investor Day today in NY - REDWOOD CITY, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Menlo...

Menlo Therapeutics to Host Investor Day October 29, 2019

-Management to Review Late Stage Development, NDA-readiness and Commercial Opportunity of Serlopitant- -Discussion to Feature two Prominent Key Opinion Leaders Well Versed in the Unmet Needs of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M

Discussion

View Full Feed
rosemountbomber rosemountbomber 3 minutes ago
And, at my advanced age, that is why I still change my own oil.  
AMRN
uber darthium uber darthium 5 minutes ago
GlobalDelCrappo

Noted and Correct
GDSI
axelvento axelvento 17 minutes ago
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA "pro-vaccine"

https://www.healthcaredive.com/news/trump-fda-martin-makary-surgeon-nominate/733829/
MRNA
TomD2046 TomD2046 17 minutes ago
Hahalolo invest site maintenance got updated to November 30th for completion... https://invest.hahalolo.com/
FBEC
shajandr shajandr 18 minutes ago
https://investorshub.advfn.com/uimage/uploads/2013/10/2/hqxjrthat-sounds-fascinating-please-go-on-thumb.jpg
crescentmotor crescentmotor 19 minutes ago
Large import duties will drive up inflation on goods and expulsion of workers who do mostly farm work and construction will drive up inflation on food and housing.

Further, tariffs will make the U.S. even less competitive in the manufacturing arena with China, which is already making
AVXL
Golfbum22 Golfbum22 20 minutes ago
Ask the lawyer

Rule of law guy

Interested also

Thx
FMCC
The ELTP King The ELTP King 23 minutes ago
Notice how Nasrat was questioning whether or not we'd have enough money for the API for the three newly acquired drugs?

This didn't include the MASSIVE 4.3 BILLION DOLLAR DRUG we just received approval on.

Keep your eyes peeled for a HUGE loan in the form of an 8-K with
API
CanItBThisEZ2Make CanItBThisEZ2Make 27 minutes ago
BEST SELLERS RANK (BSR) IS 327 46 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
rossirace9s rossirace9s 28 minutes ago
Ohhhh that's right. It changed names to Algernon Pharmaceuticals and now has a $1.57 million market cap with average 10 day volume of 3.28k shares with the same players. Sell this heaping pile before it's too late.
BLOZF
The ELTP King The ELTP King 31 minutes ago
Question: "Will Elite have enough working capital to buy all the API needed when the three new drug repurchases are launched? Or do we have to get more loans?"

Nasrat: "I believe we do, but you wouldn't know for sure until you actually go through the sales. So you see whether we hav
API
rossirace9s rossirace9s 35 minutes ago
What happened to Breathtec Biomedical?
BLOZF
The ELTP King The ELTP King 36 minutes ago
Nasrat said we're good for QUOTE "at least the next 5 years".

Who the hell knows for sure though...

With all these approvals & launches, how long do you think it will be before Elite is at full capacity with the new facility ???????
ELTP
The ELTP King The ELTP King 37 minutes ago
Thanks.

Hey Thanks A Lot King,

IB_🤴
ELTP
The ELTP King The ELTP King 38 minutes ago
Nasrat: "Our primary goal is to uplist to Nasdaq."

The King: "We need to uplist to Nasdaq."

LMAO! It's the SAME opinion.

I trust Nasrat's opinion on that topic much more than yours
ELTP
Walter4 Walter4 39 minutes ago
Sure it can go lower, same was said about one of his other companies. What is that companies share value now today when factoring in the massive reverse split? Jakes word means nothing, his actions tell all. With the way that Jake has these "companies" rigged through the 3a10 his shareholders lose e
BCAP
Humbert Humbert 40 minutes ago
Someone here said it was 1.1 billion, which I'll go by. The company should confirm this.

Either way, those multiples are a little low given the other conditions here.
BNCM
rossirace9s rossirace9s 41 minutes ago

That's a nasty 5 year chart. This is heading to all time lows. Every pump sold off. I can't believe you're still here guys. Where's AMG from the first pumps?
BLOZF
santafe2 santafe2 51 minutes ago
I'm not a big fan of fact-free commentary. I do still set you off now and then. I don't mean to but I do like Porter. I'd rather have Porter than Padilla. Porter and Schiff, I'd vote Schiff. He reminds me of Raskin here in MD. Just special politicians.
JJ8 JJ8 51 minutes ago
Pltr share price had a Bullish Triangle Breakout on 22-Nov-2024. GLTA
PLTR
catdaddy catdaddy 51 minutes ago
That makes two of you.
AVXL

Your Recent History

Delayed Upgrade Clock